Summary
VaxInnate Corporation
Founded in 2002
Description
VaxInnate is a vaccine company developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus. VaxInnate is a privately held biotechnology company in Cranbury, NJ that is pioneering breakthrough technology for use in develop...
Strengths
- VaxInnate Corporation has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since VaxInnate Corporation was founded, the company has grown faster than the industry average
Annual Revenue
VaxInnate Corporation's annual revenue
$16785000
Based on Kona Equity data
-
Revenue per employee
$250522
-
Variance of revenue growth
0.04
-
Annual revenue growth since founding
$876850
-
Revenue growth rate from first known quarter to current
46.1%
Employee Count
67 employees
-
Employee growth rate from first known quarter to current
55.0%
Executives
Kathleen Mcgowan
Cfo
k**@vaxinnate.comMary Kramer
Associate Director, Clinical Operations
m**@vaxinnate.comLynne Brown
Office Manager
l**@vaxinnate.comDavid Jackson
Vice President, Process Development & Manufacturing
d**@vaxinnate.comFuxiang Hou
Senior Research Associate
f**@vaxinnate.comGiovanna Blume
Director, Quality Systems
g**@vaxinnate.comWayne Pisano
CEO
w**@vaxinnate.comDon Macphee
Corporate Controller
d**@vaxinnate.comVanessa Diaz
Research Associate II
v**@vaxinnate.comHaijun Tian
Virology Research Scientist II
h**@vaxinnate.comMichael Ryan
Research Associate II
m**@vaxinnate.comPhone Vaxinnate
Interim Chief Executive Officer
p**@vaxinnate.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: VaxInnate Corporation
- Category: Pharmaceuticals
- Industry: Pharmaceutical Company
- SIC: 2834; 283
- NAICS: 32541; 541
See similar companies
-
By City Cranbury Small Pharmaceutical Company in Cranbury Mid-size Pharmaceutical Company in Cranbury Pharmaceuticals in Cranbury Small Pharmaceuticals in Cranbury Mid-size Pharmaceuticals in Cranbury
-
By State NJ Small companies in NJ Pharmaceuticals in NJ Small Pharmaceuticals in NJ Mid-size Pharmaceuticals in NJ Small Pharmaceutical Company in NJ Mid-size Pharmaceutical Company in NJ
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Pharmaceutical Company Small Pharmaceutical Company Mid-size Pharmaceutical Company Pharmaceuticals and Pharmaceutical Company
-
Firmographic data G Score of 6 Founded in 2002 SIC: 2834 SIC: 283 NAICS: 32541 NAICS: 541 #Pharmaceuticals #Healthcare #Biotechnology #Drug Manufacturing & Research
Frequently Asked Questions
VaxInnate Corporation's headquarters are located at 3 Cedar Brook Dr. Ste. 1 1 Cranbury, NJ 08512.
VaxInnate Corporation's official website is vaxinnate.com
VaxInnate Corporation's annual revenue is $16.8 M.
VaxInnate Corporation's SIC: 2834; 283
VaxInnate Corporation's NAICS: 32541; 541.
VaxInnate Corporation has 67 employees
VaxInnate Corporation is in the industry of Pharmaceuticals.